Prehepatic insulin production can be determined from analysis of connecting-peptide behavior in the plasma. In the present study, we have determined prehepatic insulin production in six normal men throughout a day that included three typical 750-cal meals. Total insulin secretion for the 24 h was 45.4 ∪, secreted as 10.6 ∪ with breakfast, 13.4 ∪ with lunch, and 13.8 ∪ with dinner. The remaining 7.6 ∪ was secreted during the 9 h night at a rate of 0.85 ∪/h. At least 50% of the newly secreted insulin is known to be extracted by the liver during the initial transhepatic passage, so that total peripheral delivery can be estimated as approximately 22 ∪/day. Consequently, portal vein insulin levels are in excess of those seen in peripheral blood by at least 20 ± 8 μ∪/ml in the fasted state, and by as much as 115 ± 15 μ∪/ml in the 2-h postabsorptive state. The data suggest that insulinization of the liver, without peripheral hyperinsulinemia, may be a goal of artificial insulin delivery.
Skip Nav Destination
Article navigation
Proceedings of the Kroc Foundation International Conference|
March 01 1980
“Normal” Insulin Secretion: The Goal of Artificial Insulin Delivery Systems?
R Philip Eaton;
R Philip Eaton
University of New Mexico School of Medicine and the Department of Mathematics
Albuquerque, New Mexico 87131
Search for other works by this author on:
Richard C Allen;
Richard C Allen
University of New Mexico School of Medicine and the Department of Mathematics
Albuquerque, New Mexico 87131
Search for other works by this author on:
David S Schade;
David S Schade
University of New Mexico School of Medicine and the Department of Mathematics
Albuquerque, New Mexico 87131
Search for other works by this author on:
James C Standefer
James C Standefer
University of New Mexico School of Medicine and the Department of Mathematics
Albuquerque, New Mexico 87131
Search for other works by this author on:
Diabetes Care 1980;3(2):270–273
Citation
R Philip Eaton, Richard C Allen, David S Schade, James C Standefer; “Normal” Insulin Secretion: The Goal of Artificial Insulin Delivery Systems?. Diabetes Care 1 March 1980; 3 (2): 270–273. https://doi.org/10.2337/diacare.3.2.270
Download citation file: